CLDN6 and breast carcinoma: As chemoresistance is a big problem facing the successful treatment of patients with breast cancer, and CLDN6 is expressed at a higher level in chemoresistant MCF-7/MDR cells as compared to parental MCF-7 cells, whether CLDN6 plays any role in conferring chemoresistance to breast cancer cells is unknown.